GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Days Inventory

Egyptian International Pharmaceutical Investments (CAI:PHAR) Days Inventory : 222.79 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Egyptian International Pharmaceutical Investments's Average Total Inventories for the three months ended in Dec. 2023 was E£2,239 Mil. Egyptian International Pharmaceutical Investments's Cost of Goods Sold for the three months ended in Dec. 2023 was E£917 Mil. Hence, Egyptian International Pharmaceutical Investments's Days Inventory for the three months ended in Dec. 2023 was 222.79.

The historical rank and industry rank for Egyptian International Pharmaceutical Investments's Days Inventory or its related term are showing as below:

CAI:PHAR' s Days Inventory Range Over the Past 10 Years
Min: 277.51   Med: 315.5   Max: 346.09
Current: 281.42

During the past 13 years, Egyptian International Pharmaceutical Investments's highest Days Inventory was 346.09. The lowest was 277.51. And the median was 315.50.

CAI:PHAR's Days Inventory is ranked worse than
82.03% of 974 companies
in the Drug Manufacturers industry
Industry Median: 158.355 vs CAI:PHAR: 281.42

Egyptian International Pharmaceutical Investments's Days Inventory declined from Dec. 2022 (241.38) to Dec. 2023 (222.79).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Egyptian International Pharmaceutical Investments's Inventory Turnover for the three months ended in Dec. 2023 was 0.41.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Egyptian International Pharmaceutical Investments's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.44.


Egyptian International Pharmaceutical Investments Days Inventory Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Days Inventory Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 346.09 315.50 277.51

Egyptian International Pharmaceutical Investments Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 241.38 401.02 305.60 256.81 222.79

Competitive Comparison of Egyptian International Pharmaceutical Investments's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Days Inventory distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Days Inventory falls into.



Egyptian International Pharmaceutical Investments Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Egyptian International Pharmaceutical Investments's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2161.799 + 2242.396) / 2 ) / 2896.344*365
=2202.0975 / 2896.344*365
=277.51

Egyptian International Pharmaceutical Investments's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (2235.195 + 2242.396) / 2 ) / 916.973*365 / 4
=2238.7955 / 916.973*365 / 4
=222.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Egyptian International Pharmaceutical Investments's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Egyptian International Pharmaceutical Investments's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Egyptian International Pharmaceutical Investments Days Inventory Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines